The first license was granted on August 11, 2004 to researchers at the University of Newcastle to allow them to investigate treatments for diabetes, Parkinson's disease and Alzheimer's disease.
Pirmasis toks leidimas buvo išduotas 2004 m. rugpjūčio 11 d. Niukaslo universiteto mokslininkams, tiriantiems diabetą, Parkinsono ir Alzhaimerio ligas.